Your session is about to expire
← Back to Search
Neuromuscular Stimulation
EMS users in ESRD for Dialysis
N/A
Waitlist Available
Led By Bradley S Dixon, MD
Research Sponsored by Bradley S. Dixon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 8 weeks and 16 weeks while exercising, and 4 weeks post exercise
Awards & highlights
No Placebo-Only Group
Summary
The investigators propose a pilot feasibility study to determine if exercise delivered by passive electrical muscle stimulation (EMS) in patients with end stage renal disease (ESRD) on hemodialysis improves physical fitness and insulin resistance, outcome markers associated with morbidity and mortality in this population.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 8 weeks and 16 weeks while exercising, and 4 weeks post exercise
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 8 weeks and 16 weeks while exercising, and 4 weeks post exercise
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Insulin resistance as measured by the serum Leptin-Adiponectin ratio
Secondary study objectives
Quadriceps muscle strength measured by a belt-stabilized portable dynamometer
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: EMS users in ESRDExperimental Treatment1 Intervention
Subjects then initiate passive electrical muscle stimulation (EMS) delivered by a commercially available FDA approved neuromuscular stimulator (EMPI 300PV or its replacement, EMPI Continuum device obtained from EMPI, Inc., St Paul MN) 3 times a week to the quadriceps muscle groups (15 minutes on each side, 30 minutes total) while on hemodialysis. The duration of training will last for 4 months. Subjects will be monitored at regular intervals during the training to make sure they are doing the training correctly and they are not experiencing any problems.
Find a Location
Who is running the clinical trial?
Bradley S. DixonLead Sponsor
Bradley S Dixon, MDPrincipal InvestigatorUniversity of Iowa
1 Previous Clinical Trials
12 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger